Abstract:Objective: To compare the effects of different intervention measures on prognosis and quality of life in patients with atrial fibrillation, in order to provide clinical basis for diagnosis and treatment. Methods: A total of 160 patients who visited several hospitals including Shanghai Xinhua Hospital from June 2019 to June 2021 were selected. Among them, 40 cases were in the drug treatment group (DRUG group), 40 cases in the radiofrequency ablation group (Radiofrequency ablation, RFA group), and 40 cases in the catheter ablation combined with percutaneous left atrial appendage occlusion group (""one-stop"" procedure group) and 40 cases in the percutaneous left atrial appendage closure group (Left atrial appendage closure, LAAC group). The Minnesota quality of life score (MLHFQ), ejection fraction (LVEF), and left atrial anterior and posterior diameters (LAD) were compared between the groups at 1-year follow-up, and the differences in adverse events were compared between the groups. Results: (1) After a 1-year follow-up, overall comparison, the MLHFQ scores and the LVEF and the LAD among the four groups were statistically different (p < .01); (2) Multiple comparisons, ① the MLHFQ scores: The RFA group was the lowest, the "one-stop" operation group was lower than the DRUG group, the LAAC group was the highest (p < .01). ② LVEF: The RFA group was the highest, the "one-stop" procedure group was higher than the drug treatment group, the LAAC group was the lowest (p < .01). ③ LAD: the RFA group and the "one-stop" procedure group were smaller than the DRUG group, the DRUG group was smaller than the LAAC group (p < .01).(3) Compared with the baseline data after 1-year follow-up in each group, in the RFA group and in the "one-stop" procedure group, the MLHFQ scores was decreased, the LVEF was increased, and the LAD was decreased (p < .01); in the DRUG group: the difference was not statistically significant (p > .05); in the LAAC group, the MLHFQ scores was increased, the LVEF was decreased, and the LAD was increased (p < .01). (4) There were significant differences in the incidence of adverse events among the four groups (p < .01), the lowest in the RFA group and the highest in the LAAC group. Conclusion: Compared with drug treatment, radiofrequency ablation and "one-stop" procedure group can improve the quality of life of patients with atrial fibrillation, improve cardiac function, and reduce the occurrence of adverse events. Percutaneous left atrial appendage occlusion affects patients' quality of life and improves cardiac function, and increases the incidence of adverse events.

Improvement effect of rosuvastatain on atrial electrical remodelling in persistent atrial fibrillation

The effects of amiodarone on QT dispersion in patients with atrial fibrillation

Clinical efficacy observation of Amiodarone and Metoprolol on elderly paients with coronary heart disease by cardiac arrhythmias

Effect of Oral Propafenone on Reversing Paroxysmal Atrial Fibrillation with No Rheumatic Disease

Effect of Amiodarone on Reversion of Atrial Remodeling in Patients with Idiopathic Atrial Fibrillation

The effect of radiofrequency catheter ablation on cardiac reverse remodeling in cardiomyopathy patients with paroxysmal atrial fibrillation

The effects of cardiac resynchronization and pharmacological treatment to control ventricular rate in chronic heart failure patients and coexistent persistent atrial fibrillation

Effect of annular pulmonary vein electrical isolation method on reversal and remodeling cardiomyopathic patients with paroxysmal atrial fibrillation

A study on the intervention effect of enalpril on atrial fibrillation

The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation after Catheter Ablation

A comparison different rate-control in patients with heart failure and atrial fibrillation underwent resynchronization therapy

Effect of Postablation Monitoring Strategy on Long-Term Outcome for Catheter Ablation of Persistent Atrial Fibrillation

Effect of Simvastatin on Acute Coronary Syndrome Complicated with Atrial Fibrillation

Clinical Observation on Efficacy of Irbesartan Combined with Atorvastatin in Treatment of Hyper-tension Complicated with Paroxysmal Atrial Fibrillation

Evaluation of rosuvastatin in preventing early recurrence of persistent atrial fibrillation after catheter ablation treatment

Effects of metoprolol on atrial remodeling in rats with acute myocardial infarction

The Effects of Right Ventricular Outflow Tract Septa and Right Ventricular Apical Pacing on Cardiac Remodeling, Aldosterone and Angiotensin II

Efficacy of cardiac resynchronization therapy in chronic heart failure patients with persistent atrial fibrillation

Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation

Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis

Effects of different interventions on prognosis and quality of life in patients with atrial fibrillation